首页> 外文OA文献 >Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer

【2h】

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer

机译：随机两副两决阶段试验的主要结果将Neoadjuvant化疗与二氯丁/ S-1和Docetaxel / Cisplatin / S-1中的两种和四种疗程进行比较，作为晚期胃癌的新辅助化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tsutomu Hayashi; Takaki Yoshikawa; Kentaro Sakamaki; Kazuhiro Nishikawa; Kazumasa Fujitani; Kazuaki Tanabe; Kazunari Misawa; Takanori Matsui; Akira Miki; Hiroshi Nemoto; Tetsu Fukunaga; Yutaka Kimura; Jun Hihara;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer [J] . Tsutomu Hayashi, Takaki Yoshikawa, Kentaro Sakamaki, Annals of Gastroenterological Surgery . 2020,第5期

机译：随机两副两决阶段试验的主要结果将Neoadjuvant化疗与二氯丁/ S-1和Docetaxel / Cisplatin / S-1中的两种和四种疗程进行比较，作为晚期胃癌的新辅助化疗
2. Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer [J] . Aoyama T., Nishikawa K., Fujitani K., Annals of oncology: official journal of the European Society for Medical Oncology . 2017,第8期

机译：随机两副两端阶段试验的早期结果将Neoadjuvant化疗与二氯丁/ S-1和Docetaxel / Cisplatin / S-1中的两种和四种疗程进行比较，作为Neoadjuvant化疗，用于局部晚期胃癌
3. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer [J] . Yoshikawa Takaki, Morita Satoshi, Tanabe Kazuaki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：比较新辅助化疗与两至四个疗程的S-1加顺铂（SC）和紫杉醇加顺铂（PC）联合D2胃切除术治疗可切除的晚期胃癌的随机二乘二因子II期试验的生存结果
4. Predicting the Response to Chemotherapy in Gastric Adenocarcinoma: Who Benefits from Neoadjuvant Chemotherapy? [C] . William B. Robb, Christophe Mariette St. Gallen EORTC Gastrointestinal Cancer Conference . 2012

机译：预测胃腺癌中疗的反应：谁从Neoadjuvant化疗中受益？
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer [O] . Tsutomu Hayashi, Takaki Yoshikawa, Kentaro Sakamaki, 2020

机译：随机两副两决阶段试验的主要结果将Neoadjuvant化疗与二氯丁/ S-1和Docetaxel / Cisplatin / S-1中的两种和四种疗程进行比较作为晚期胃癌的新辅助化疗
7. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer [O] . Yoshikawa Takaki, Morita Satoshi, Tanabe Kazuaki, 2016

机译：比较新辅助化疗与两至四个疗程的S-1加顺铂（SC）和紫杉醇加顺铂（PC）联合D2胃切除术治疗可切除的晚期胃癌的随机二乘二因子II期试验的生存结果

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer

著录项

引文网络

相似文献

相关主题

期刊订阅